2027 NCODA Global Oncology & Haematology Congress
March 10, 2027 | 9:00 AM EST
- Home
- Clinical Resources Search
- PQI: Mirvetuximab soravtansine-gynx (Elahere®) for Patients with Platinum-Resistant Ovarian, Fallopian tube, or Primary Peritoneal Cancer
Mirvetuximab soravtansine-gynx (Elahere®) for Patients with Platinum-Resistant Ovarian, Fallopian tube, or Primary Peritoneal Cancer
Download PQI pdf
Last Updated: January 30, 2025
By: Aisha Grant, PharmD, BCOP, BCPS | Jeanine Ewing, PharmD, BCOP
About this PQI
The purpose of this PQI is to discuss clinical considerations surrounding the use of mirvetuximab soravtansine-gynx for patients with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer.
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Retifanlimab-dlwr in Combination with CARBOplatin + PACLItaxel for the First-Line Treatment of Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal
Last Updated: 10/21/2026
PQI: Ruxolitinib Extended Release for the Management of Myelofibrosis, Polycythemia Vera, and Graft-Versus-Host Disease
Last Updated: 10/21/2026
PQI: Gedatolisib Combination Therapy for Locally Advanced or Metastatic Breast Cancer
Last Updated: 10/15/2026
PQI: Relacorilant (LIFYORLI) and Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Platinum-Resistant Ovarian Cancer
Last Updated: 09/09/2026
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Inavolisib (Itovebi) Patient Management
Last Updated: 08/01/2026
PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia
Last Updated: 06/30/2026
PQI in Action: Capivasertib (Truqap) Patient Management
Last Updated: 05/06/2026
PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)
Last Updated: 04/01/2026
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S11 E9: Keep Saying Yes: Living, Advocating, and Finding Purpose with Cancer
Last Updated: 10/24/2026
S11 E10: Fungi, Facts, and Cancer Care: Exploring Medicinal Mushrooms
Last Updated: 10/24/2026
S11 E8: The Future of Oncology
Last Updated: 10/24/2026
S11 E7: Your Health Story in One Place
Last Updated: 10/24/2026
Toolkit
Toolkit
Toolkit: Simplify CLL Tracking in Oncology Practices
Last Updated: 10/15/2025
Toolkit: Optimize CLL Care in Epic
Last Updated: 10/15/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 01/06/2026
Treatment Support Kit: Bispecific (T-Cell Engager)
Last Updated: 12/12/2025
Treatment Support Kit: Zanidatamab-hrii
Last Updated: 09/28/2025
Treatment Support Kit: Avutometinib and Defactinib
Last Updated: 08/06/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 10/24/2026
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Last Updated: 10/24/2026
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Last Updated: 10/24/2026
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Last Updated: 10/24/2026
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Avutometinib and Defactinib
Last Updated: 07/15/2026
Cisplatin and Etoposide
Last Updated: 06/10/2026
Pembrolizumab and Paclitaxel
Last Updated: 05/11/2026
Relacorilant and Albumin-Bound Paclitaxel
Last Updated: 04/28/2026
PQI
PQI
Patient Education Sheet
Patient Education Sheet
PQI: Avutometinib and Defactinib (Avmapki Fakzynja Co-Pack) for the Management of KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC)
Last Updated: 10/06/2026
PQI: Relacorilant (LIFYORLI) and Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Platinum-Resistant Ovarian Cancer
Last Updated: 09/09/2026
Dactinomycin
Last Updated: 08/31/2026
Carboplatin and Docetaxel
Last Updated: 08/24/2026
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Avutometinib and Defactinib
Last Updated: 07/15/2026
Cisplatin and Etoposide
Last Updated: 06/10/2026
Pembrolizumab and Paclitaxel
Last Updated: 05/11/2026
Relacorilant and Albumin-Bound Paclitaxel
Last Updated: 04/28/2026
Patient Education Sheet
PQI
Eribulin and Margetuximab
Last Updated: 05/07/2026
PQI: Margetuximab-cmkb (MARGENZA®) Management
Last Updated: 07/05/2023
PQI
PQI
Patient Education Sheet
Patient Education Sheet
PQI: Retifanlimab-dlwr in Combination with CARBOplatin + PACLItaxel for the First-Line Treatment of Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal
Last Updated: 10/21/2026
PQI: Ruxolitinib Extended Release for the Management of Myelofibrosis, Polycythemia Vera, and Graft-Versus-Host Disease
Last Updated: 10/21/2026
Rusfertide (Mimrylo)
Last Updated: 10/19/2026
Lirafugratinib (Lyrfigtu)
Last Updated: 10/19/2026